External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ESMO Breast Cancer 2021
Roche and Genentech at

ESMO Breast Cancer 2021

May 05 - May 08
Virtual
esmo.org/meetings
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
05:28 PM
Duration 12mins Virtual
Biomarker analysis from KAITLIN, a randomised phase 3 study of adjuvant trastuzumab emtansine plus pertuzumab versus trastuzumab plus taxane plus pertuzumab after anthracyclines for high-risk HER2-positive early breast cancer
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:40 PM
Duration 12mins Virtual
Pertuzumab/Trastuzumab in Early Stage HER2-positive Breast Cancer: 5-year and Final Analysis of the BERENICE Trial
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.